FIRSTEC (A010820) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
23 Nov, 2025Executive summary
Operates a single domestic segment focused on defense industry products, with a strong track record in major weapons systems and control equipment development and production since 1975.
2025 Q3 sales were ₩186.4 billion, with a net income of ₩6.68 billion, reflecting a recovery from the previous year.
The company maintains a robust R&D program, investing ₩845 million in the first nine months of 2025, and holds 25 registered patents.
Financial highlights
Revenue for 2025 Q3 (YTD) was ₩186.4 billion, down from ₩207.3 billion in 2024, but up from ₩173.1 billion in 2023.
Operating income for 2025 Q3 was ₩5.79 billion, up from ₩4.35 billion in 2024 Q3.
Net income for 2025 Q3 was ₩6.68 billion, compared to ₩2.87 billion in 2024 Q3.
Total assets at Q3 2025 were ₩388.4 billion, with equity of ₩70.6 billion.
Cash and equivalents at Q3 2025 were ₩49.6 billion, down from ₩94.4 billion at 2024 year-end.
Outlook and guidance
The company is targeting expansion in unmanned systems and aerospace, aiming for a top-10 domestic defense industry ranking.
Ongoing investments in R&D and production capacity are expected to support future growth and competitiveness.
Latest events from FIRSTEC
- FY2025 revenue up 42.2% and net income up 34.9%, with strong cash and no debt.A010820
Q4 202522 Mar 2026 - Q1 2025 revenue reached ₩53.6B with net income of ₩2.19B, driven by defense contracts.A010820
Q1 202525 Aug 2025 - Revenue and profit fell, but cash and assets rose as R&D and market expansion continued.A010820
Q3 202425 Aug 2025 - Revenue fell but net income turned positive; focus remains on R&D and future defense growth.A010820
Q2 202525 Aug 2025 - H1 2024 saw higher revenue and net income, with robust defense sales and increased cash reserves.A010820
Q2 202425 Aug 2025 - Revenue and net income surged, but leverage increased; 2025 outlook remains cautious.A010820
Q4 202425 Aug 2025